VIPMED International

  • Română


Revolutionary Device in the Fight Against Prostate Cancer

Early detection of the diagnosis you are facing can significantly influence the clinical management of the disease.

Prostate cancer remains one of the leading causes of cancer-related deaths in men. Through this advanced revolutionary technique – 68Ga-PSMA, you can obtain precise information about the stage of your disease.

The PET investigation with a radiotracer [68Ga]-gallium-labelled Prostate-Specific Membrane Antigen (68Ga-PSMA) has proven to be highly successful in investigating and diagnosing prostate cancer, especially in detecting recurrences and metastases of prostate cancer. Moreover, molecular PET imaging with 68Ga-PSMA highlights suspicious lesions for prostate cancer with very good contrast and a very high detection rate, even when the prostate-specific antigen level is low.

This investigation is a vital element of today’s medical practice, adding an additional dimension to the early diagnosis of prostate cancer.

For detailed information and/or appointment requests at one of the collaborating hospitals, please contact us at:

+4 0732 056 272
+4 0732 056 273
+4 0720 488 499